Introduzca los términos de búsqueda.

Web Fuerteventura Digital Envíe el formulario de búsqueda

 •INICIO  •HOME

Viajes a Fuerteventura

Pincha Para Ver los Pronosticos de Maldini de la Jornada

LAS NOTICIAS DE CANARIAS,ESPAÑA *
E INTERNACIONAL CON SECCIONES
COMO VIDEOS,Y MAS EN NOTICANARIAS

1 Julio, 2009 

Zacks Analyst Blog Highlights: J.P. Morgan, Bank of America, Citigroup, Wells Fargo and Omnicell Inc. CHICAGO--(BUSINESS WIRE)--Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: J.P. Morgan (NYSE: JPM), Bank of America (NYSE: BAC), Citigroup (NYSE: C), Wells Fargo (NYSE: WFC) and Omnicell Inc. (Nasdaq: OMCL). Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579 Here are highlights from Monday’s Analyst Blog: Supreme Court Rules Against Banks In a surprising 5-4 vote, the Supreme Court ruled that national banks are still subject to the laws of the states they operate in. What made the ruling unusual is that Justice Scalia wrote the opinion and the other four conservative judges were in dissent (Roberts, Thomas, Alito and the normal swing vote Kennedy). The ruling overturned an appeals court ruling that said that state attorney generals cannot investigate banks if they operate in more than one state. The case in question involved the enforcement of fair lending laws in N.Y. State, specifically allegations that some banks were charging minorities higher interest rates. Instead, even though these are state laws, the appeals court had said that only the Office of the Comptroller of the Currency (OCC) had the power to investigate. In practice, this means that the laws were null and void, since the OCC has a lousy track record on such issues. Enforcing state laws is simply not a priority for a division of the Treasury Department. While clearly there can be a problem if multiple agencies have jurisdiction in regulation, allowing things to slip through the cracks, there can also be problems when there is only one regulator and that regulator is in the pocket of the regulated. It is harder to capture all 50 state attorney generals and the OCC, than it is just the OCC alone. Make no mistake, the head of the OCC, John Dugan, a holdover from the last administration, is very much a creature of the big banks he is supposed to be overseeing. The OCC ranks just behind the OTS in being an ineffectual regulator during the bubble. While the state attorney generals will not be able to issue subpoenas on their own authority (they need approval from a state judge), it does mean that they do not have to sit on their hands if they think the banks are breaking the law. It also will mean a more fair application of the law. If the appeals court ruling had been allowed to stand, then the state attorney generals would have been free to go after a little community bank that only operated in their state, but unable to go after the big banks like J.P. Morgan (NYSE: JPM), Bank of America (NYSE: BAC), Citigroup (NYSE: C) and Wells Fargo (NYSE: WFC) that dominate the banking business. Sort of like telling them, yeah, it’s okay for the state to go after the street level drug traffickers, but not allowed to go after the kingpins. This is a major win for consumer protection, and a loss for the banks. It is also a big win for states in the ongoing struggle between state and federal jurisdiction. I guess the Supreme Court is not as susceptible to campaign contribution influence as the Congress is. Omnicell Stays on Hold Headquartered in Mountain View, CA, Omnicell Inc. (Nasdaq: OMCL) founded in 1992, develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. These solutions enable healthcare facilities to acquire, manage, dispense and deliver pharmaceuticals and medical supplies, as well as enhance patient safety, reduce medication errors, improve workflow, and increase operational efficiency. Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=2649.